Input sequence

Protein name Complement receptor type 2
Organism Homo sapiens Length 1033
Disorder content 0.4% ProS content 0.4%
IDEAL NA UniProt P20023

Prediction

Order Disorder ProS BLAST:PDB BLAST:PDB BLAST:PDB BLAST:PDB BLAST:PDB BLAST:PDB BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP SEG:LCR TMHMM:TMhelix 0 1033 1-1029 1030-1033 1-1029 1030-1033 1030-1033 22-149 409-657 153-406 602-845 737-968 293-522 91-211 21-149 526-817 276-471 719-957 89-273 408-593 276-342 527-593 851-907 154-210 410-466 23-82 91-146 154-210 215-271 276-342 351-406 410-466 527-593 602-657 719-779 788-843 851-907 912-968 584-754 397-567 770-945 73-248 274-343 21-83 526-611 719-797 215-287 349-407 931-968 21-83 88-149 151-211 213-273 274-343 349-407 408-467 525-594 600-658 660-716 717-780 785-845 849-908 910-969 2-20 984-998 976-998 1ly2A(3-130) 1e-75 99.22% 2xrbA(1-252) 8e-39 34.72% 2xrbA(1-252) 8e-38 33.85% 3o8eB(1-251) 2e-30 31.27% 1g40A(24-242) 2e-19 28.69% 1g40A(23-242) 4e-18 29.17% 1e5gA(3-119) 4e-11 34.13% 1ly2A(2-130) 3e-32 98.45% 2ok5A(3-277) 9e-26 19.02% 2ok5A(4-190) 9e-26 20.4% 2ok5A(4-237) 8e-25 19.51% 3sw0X(2-186) 2e-12 26.94% 2mcyA(1-131) 4e-12 31.72% PF00084(1-56) 7e-06 49.25% PF00084(1-56) 1e-05 47.76% PF00084(1-56) 1e-05 47.37% PF00084(1-56) 6e-05 49.12% PF00084(1-56) 0.0002 40.35% PF00084 1.6e-18 72.2% PF00084 2.7e-15 61.4% PF00084 4.7e-14 57.3% PF00084 2.1e-14 58.5% PF00084 3.4e-13 54.4% PF00084 8.5e-15 59.8% PF00084 9.5e-20 76.2% PF00084 7.5e-19 73.2% PF00084 9.8e-16 62.9% PF00084 2.8e-18 71.4% PF00084 2.4e-11 48.3% PF00084 3.1e-16 64.6% PF00084 8.5e-11 46.5% 1vavA(4-153) 4e-23 11.49% 1vavA(4-158) 3e-17 11.11% 1vavA(4-151) 7e-17 12.29% 1vavA(4-153) 5e-10 10.67% 1gpzA2(1-66) 1e-11 24.29% 1gpzA2(1-66) 5e-07 22.73% 1c1zA5(1-79) 4e-09 9.68% 1c1zA5(2-79) 1e-08 12.79% 1c1zA5(2-80) 0.0003 12.05% 1c1zA4(1-59) 2e-10 31.67% 1c1zA2(19-56) 2e-06 28.95% g.18.1 2.4e-17 54.9% g.18.1 3.6e-14 41.1% g.18.1 5.1e-18 52.1% g.18.1 1.2e-12 40.3% g.18.1 4.8e-21 66.4% g.18.1 7.9e-18 56.4% g.18.1 1.6e-19 61.7% g.18.1 9e-24 74.8% g.18.1 1.2e-17 55.8% g.18.1 2.4e-06 21.5% g.18.1 2.9e-20 64.0% g.18.1 8.1e-16 45.8% g.18.1 3e-19 60.8% g.18.1 3e-15 48.3%

Sequence

MGAAGLLGVFLALVAPGVLGISCGSPPPILNGRISYYSTPIAVGTVIRYSCSGTFRLIGE
KSLLCITKDKVDGTWDKPAPKCEYFNKYSSCPEPIVPGGYKIRGSTPYRHGDSVTFACKT
NFSMNGNKSVWCQANNMWGPTRLPTCVSVFPLECPALPMIHNGHHTSENVGSIAPGLSVT
YSCESGYLLVGEKIINCLSSGKWSAVPPTCEEARCKSLGRFPNGKVKEPPILRVGVTANF
FCDEGYRLQGPPSSRCVIAGQGVAWTKMPVCEEIFCPSPPPILNGRHIGNSLANVSYGSI
VTYTCDPDPEEGVNFILIGESTLRCTVDSQKTGTWSGPAPRCELSTSAVQCPHPQILRGR
MVSGQKDRYTYNDTVIFACMFGFTLKGSKQIRCNAQGTWEPSAPVCEKECQAPPNILNGQ
KEDRHMVRFDPGTSIKYSCNPGYVLVGEESIQCTSEGVWTPPVPQCKVAACEATGRQLLT
KPQHQFVRPDVNSSCGEGYKLSGSVYQECQGTIPWFMEIRLCKEITCPPPPVIYNGAHTG
SSLEDFPYGTTVTYTCNPGPERGVEFSLIGESTIRCTSNDQERGTWSGPAPLCKLSLLAV
QCSHVHIANGYKISGKEAPYFYNDTVTFKCYSGFTLKGSSQIRCKADNTWDPEIPVCEKE
TCQHVRQSLQELPAGSRVELVNTSCQDGYQLTGHAYQMCQDAENGIWFKKIPLCKVIHCH
PPPVIVNGKHTGMMAENFLYGNEVSYECDQGFYLLGEKKLQCRSDSKGHGSWSGPSPQCL
RSPPVTRCPNPEVKHGYKLNKTHSAYSHNDIVYVDCNPGFIMNGSRVIRCHTDNTWVPGV
PTCIKKAFIGCPPPPKTPNGNHTGGNIARFSPGMSILYSCDQGYLLVGEALLLCTHEGTW
SQPAPHCKEVNCSSPADMDGIQKGLEPRKMYQYGAVVTLECEDGYMLEGSPQSQCQSDHQ
WNPPLAVCRSRSLAPVLCGIAAGLILLTFLIVITLYVISKHRARNYYTDTSQKEAFHLEA
REVYSVDPYNPAS

Region:1-1033
Length:1033aa
Label:Full sequence
Reset:click